DelveInsight

DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
  • Company’s profile and licensing data;
  • New technology studies;
  • Biologic benchmarking;
  • Treatment modality analysis;
  • Competitive landscape;
  • Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.

DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.


Research Reports By DelveInsight

Found 2467 publications
Prograf- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Nuvigil - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Myfortic - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Loestrin 24 Fe- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Integrilin - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Geninax - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Efient - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
Cubicin- Drug Insight, 2019 US$ 1,000.00 Jan, 2019 35 pages
Chronic Plaque Psoriasis - Pipeline Insight, 2019 US$ 1,500.00 Jan, 2019 70 pages
Bronchitis - Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 50 pages
Autism - Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 50 pages
Alimta - API Insight, 2019 US$ 500.00 Jan, 2019 30 pages
TIM-3 Antagonist -Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 60 pages
Muscarinic M1 Agonist -Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 60 pages
Glycan Inhibitor -Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 60 pages
D3 Agonist -Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 60 pages
Arginine Depletors -Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 60 pages
Uveitis - Epidemiology Forecast to 2028 US$ 3,250.00 Jan, 2019 50 pages
Upadacitinib - Launch Insight, 2019 US$ 1,500.00 Jan, 2019 50 pages
Polycystic Kidney Disease - Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 50 pages
Periodontal Disease - Pipeline Insight, 2019 US$ 1,250.00 Jan, 2019 50 pages
1 2 3 4 5 ... 50
Skip to top

Analytics & News by DelveInsight